Flower City Capital

Position in IMRX — Immuneering Corp

CIK 1808394 PITTSFORD, NY

Position in IMRX

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$274,594

-$15,408 QoQ

Shares Held

55,029

0.0% QoQ

Ownership

0.085%

of shares outstanding

% of Portfolio

1.95%

of 13F equity value

Holder Rank

#50

of 111 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Flower City Capital holds $929,624 across 5 Biotechnology names. IMRX ranks #2 (29.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	500	$311,770
2	IMRX	Immuneering Corp This page	55,029	$274,594
3	KURA	Kura Oncology, Inc.	18,000	$197,460
4	PGEN	Precigen, Inc.	20,000	$114,000
5	OTLK	Outlook Therapeutics, Inc.	20,000	$31,800

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,594	55,029	0.0%	Shares	Sole	2026-07-07
2026-03-31	$290,002	55,029	+30.3%	Shares	Sole	2026-04-14
2025-12-31	$277,866	42,229	+44.5%	Shares	Sole	2026-01-22
2025-09-30	$204,603	29,229	-8.7%	Shares	Sole	2025-10-08
2025-06-30	$107,937	32,029	—	Shares	Sole	2025-07-16
No filing history on record for this holder in this stock.